本页面由Tiger Trade Technology Pte. Ltd.提供服务

PMV Pharmaceuticals

1.32
-0.0100-0.75%
盘后1.320.00000.00%16:10 EDT
成交量:25.92万
成交额:33.85万
市值:7,023.92万
市盈率:-0.89
高:1.33
开:1.32
低:1.29
收:1.33
52周最高:1.88
52周最低:0.8100
股本:5,321.15万
流通股本:3,620.46万
量比:0.87
换手率:0.72%
股息:- -
股息率:- -
每股收益(TTM):-1.4800
每股收益(LYR):-1.4800
净资产收益率:-55.37%
总资产收益率:-35.00%
市净率:0.67
市盈率(LYR):-0.89

数据加载中...

2021/05/07

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/04/06

重要事件披露

8-K - Current report
2021/03/03

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/03

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/13

重要事件披露

8-K - Current report
2020/10/05

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/10/05

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/09/30

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/09/29

重要事件披露

8-K - Current report
2020/09/28

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/09/24

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/09/21

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/09/04

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933